Details for New Drug Application (NDA): 020587

✉ Email this page to a colleague

NDA 020587 describes SCLEROSOL, which is a drug marketed by Sciarra Labs and is included in one NDA. Additional details are available on the SCLEROSOL profile page.

The generic ingredient in SCLEROSOL is talc. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the talc profile page.

Summary for 020587

Tradename:	SCLEROSOL
Applicant:	Sciarra Labs
Ingredient:	talc
Patents:	0

Medical Subject Heading (MeSH) Categories for 020587

Antiperspirants

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	AEROSOL;INTRAPLEURAL			Strength	4GM/SPRAY
Approval Date:	Dec 24, 1997	TE:		RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.